StockData
biote Corp. logo

biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3066% below fair value
$0.81−0.03 (-3.56%)

Close on Nov 20, 2026Market cap $29.27MP/E 8.1Yield –

biote gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

biote's gross profit for the twelve months ending Jun 30, 2026 was $125.86M, down 12.2% year over year. For fiscal 2025 it was $137.36M, down 1.2% from the year before. The highest annual figure on record is $139.06M in fiscal 2024.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$137.36M-1.2%
FY2024Dec 31, 2024$139.06M+9.1%
FY2023Dec 31, 2023$127.48M+15.5%
FY2022Dec 31, 2022$110.38M+21.9%
FY2021Dec 31, 2021$90.58M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$28.92M-17.3%
Q1 FY2026Mar 31, 2026$30.95M-14.9%
Q4 FY2025Dec 31, 2025$31.57M-11.8%
Q3 FY2025Sep 30, 2025$34.42M-4.7%
Q2 FY2025Jun 30, 2025$34.99M+3.5%
Q1 FY2025Mar 31, 2025$36.38M+9.1%
Q4 FY2024Dec 31, 2024$35.80M+12.9%
Q3 FY2024Sep 30, 2024$36.11M+15.0%
Q2 FY2024Jun 30, 2024$33.81M+1.1%
Q1 FY2024Mar 31, 2024$33.35M+7.7%
Q4 FY2023Dec 31, 2023$31.70M+9.1%
Q3 FY2023Sep 30, 2023$31.39M+9.6%
Q2 FY2023Jun 30, 2023$33.43M+20.2%
Q1 FY2023Mar 31, 2023$30.97M+24.5%
Q4 FY2022Dec 31, 2022$29.06M+21.0%
Q3 FY2022Sep 30, 2022$28.63M+23.0%
Q2 FY2022Jun 30, 2022$27.82M+20.4%
Q1 FY2022Mar 31, 2022$24.87M–
Q4 FY2021Dec 31, 2021$24.01M–
Q3 FY2021Sep 30, 2021$23.28M–
Q2 FY2021Jun 30, 2021$23.11M–

More biote figures

See a number that looks wrong?